<div><b>References</b></div><div>1. Roelofs, R.L., Janssen, N., Wingbermühle, E., Kessels, R.P., Egger,
J.I. (2016). Intellectual development in Noonan syndrome: a longitudinal
study. Brain and Behavior, 3;6( 7).<i>https://doi.org/10.1002/brb3.479</i> .</div><div>2. Yart, A., Edouard, T. (2018). Noonan syndrome: an update on growth
and development. Current Opinion in Endocrinology &amp; Diabetes and
Obesit; 25( 1):67-73. doi: 10.1097/MED.0000000000000380.</div><div>3. Altmüller F, Lissewski C, Bertola D, Flex E, Stark Z, Spranger S,
Baynam G, Buscarilli M, Dyack S, Gillis J, Yntema HG, Pantaleoni F, van
Loon RL, MacKay S, Mina K, Schanze I, Tan TY, Walsh M, White SM,
Niewisch MR, García-Miñaúr S, Plaza D, Ahmadian MR, Cavé H, Tartaglia M,
Zenker M.  (2017). Genotype and phenotype spectrum of NRAS germline
variants. European Journal of Human Genetics 25( 7):823-831.
https://doi.org/10.1038/ejhg.2017.65.</div><div>4. El Bouchikhi, I., Belhassan, K., Moufid, F.Z., Iraqui Houssaini, M.,
Bouguenouch, L., Samri, I., Atmani, S., Ouldim, K. (2016). Noonan
syndrome-causing genes: Molecular update and an assessment of the
mutation rate. International Journal of Pediatrics and Adolescent
Medicine, 3( 4):133-142. https://doi.org/10.1016/j.ijpam.2016.06.003.</div><div>5. Shaw, A.C., Kalidas, K., Crosby, A.H., Jeffery, S., Patton, M.A.
(2007). The natural history of Noonan syndrome: a long-term follow-up
study. Archives of Disease in Childhood; 92( 2):128-32.
http://dx.doi.org/10.1136/adc.2006.104547.</div><div>6. Pavone, P., Praticò, A.D., Rizzo, R., Corsello, G., Ruggieri, M.,
Parano, E., Falsaperla, R. (2017). A clinical review on megalencephaly:
A large brain as a possible sign of cerebral impairment. Medicine
(Baltimore), 96(26):e6814. doi: 10.1097/MD.0000000000006814.</div><div>7.Pirozzi, F, Nelson, B, Mirzaa, G. (2018). From microcephaly to
megalencephaly: determinants of brain size. Dialogues in clinical
neuroscience, 20(4):267-282. doi: 10.31887/DCNS.2018.20.4/gmirzaa.</div><div>8. Döcker, D., Schubach, M., Menzel, M., Spaich, C., Gabriel, H.D.,
Zenker, M., Bartholdi, D., Biskup S. (2015). Germline PTPN11 and somatic
PIK3CA variant in a boy with megalencephaly-capillary malformation
syndrome (MCAP) pure coincidence? European Journal of Medical Genetics,
23( 3), 409-12. https://doi.org/10.1038/ejhg.2014.118.</div><div>9. Gripp KW, Zand DJ, Demmer L, Anderson CE, Dobyns WB, Zackai EH,
Denenberg E, Jenny K, Stabley DL, Sol-Church K. (2013). Expanding the
SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen
hair: structural brain anomalies and myelofibrosis. American Journal of
Medical Genetics part A, 161A( 10):2420-30.
https://doi.org/10.1002/ajmg.a.36098.</div><div>10. Myers A, Bernstein JA, Brennan ML, Curry C, Esplin ED, Fisher J,
Homeyer M, Manning MA, Muller EA, Niemi AK, Seaver LH, Hintz SR, Hudgins
L. (2014). Perinatal features of the RASopathies: Noonan syndrome,
cardiofaciocutaneous syndrome and Costello syndrome. American Journal of
Medical Genetics part A, 164A(11):2814-21.
https://doi.org/10.1002/ajmg.a.36737.</div><div>11. De Castro, R.L. Jr, de Alcantara Lima, N., da Costa Lino, D.O.,
Bannon, S.F. (2019). Concealed Wolff-Parkinson-White Syndrome revealed
by acute coronary syndrome. Annals of Noninvasive Electrocardiology, 19.
https://doi.org/10.1111/anec.12735.</div><div>12. Miyamoto, L. (2018). Molecular Pathogenesis of Familial
Wolff-Parkinson-White Syndrome. Journal of Medical Investigation, 65(
1.2):1-8. https://doi.org/10.2152/jmi.65.1.</div><div>13. Keppler-Noreuil KM, Rios JJ, Parker VE, Semple RK, Lindhurst MJ,
Sapp JC, Alomari A, Ezaki M, Dobyns W, Biesecker LG. (2015).
PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing
eligibility criteria, differential diagnosis, and evaluation. American
Journal of Medical Genetics part A, 167A( 2):287-95.<i>https://doi.org/10.1002/ajmg.a.36836</i>.</div>